MX2023002054A - Procesos de cultivo celular. - Google Patents
Procesos de cultivo celular.Info
- Publication number
- MX2023002054A MX2023002054A MX2023002054A MX2023002054A MX2023002054A MX 2023002054 A MX2023002054 A MX 2023002054A MX 2023002054 A MX2023002054 A MX 2023002054A MX 2023002054 A MX2023002054 A MX 2023002054A MX 2023002054 A MX2023002054 A MX 2023002054A
- Authority
- MX
- Mexico
- Prior art keywords
- cell culture
- culture processes
- processes
- proteins
- antibodies
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención pertenece al campo de la producción de proteínas recombinantes, particularmente proteínas, como los anticuerpos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2012991.2A GB202012991D0 (en) | 2020-08-20 | 2020-08-20 | Cell culture processes |
PCT/EP2021/073094 WO2022038250A1 (en) | 2020-08-20 | 2021-08-19 | Cell culture processes |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2023002054A true MX2023002054A (es) | 2023-03-16 |
Family
ID=72660828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023002054A MX2023002054A (es) | 2020-08-20 | 2021-08-19 | Procesos de cultivo celular. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20230348850A1 (es) |
EP (1) | EP4200432A1 (es) |
JP (1) | JP2023538581A (es) |
KR (1) | KR20230051277A (es) |
CN (1) | CN115916814A (es) |
AR (1) | AR123289A1 (es) |
AU (1) | AU2021329034A1 (es) |
BR (1) | BR112023002377A2 (es) |
CA (1) | CA3190220A1 (es) |
GB (1) | GB202012991D0 (es) |
IL (1) | IL300509A (es) |
MX (1) | MX2023002054A (es) |
WO (1) | WO2022038250A1 (es) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2243827B2 (en) | 1996-08-30 | 2017-11-22 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
WO2008013809A1 (en) | 2006-07-24 | 2008-01-31 | Amgen Inc. | Cell culture methods |
CA2687082C (en) | 2007-05-11 | 2014-01-14 | Amgen Inc. | Improved feed media |
US20110262965A1 (en) | 2010-04-23 | 2011-10-27 | Life Technologies Corporation | Cell culture medium comprising small peptides |
EP3330370B1 (en) | 2010-04-26 | 2021-02-24 | Novartis AG | Process for cultivation of cho cells |
WO2013158275A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Cell culture methods to reduce acidic species |
US20130281355A1 (en) | 2012-04-24 | 2013-10-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
GB201411320D0 (en) | 2014-06-25 | 2014-08-06 | Ucb Biopharma Sprl | Antibody construct |
-
2020
- 2020-08-20 GB GBGB2012991.2A patent/GB202012991D0/en not_active Ceased
-
2021
- 2021-08-19 AR ARP210102334A patent/AR123289A1/es unknown
- 2021-08-19 MX MX2023002054A patent/MX2023002054A/es unknown
- 2021-08-19 CA CA3190220A patent/CA3190220A1/en active Pending
- 2021-08-19 EP EP21765907.7A patent/EP4200432A1/en active Pending
- 2021-08-19 BR BR112023002377A patent/BR112023002377A2/pt unknown
- 2021-08-19 AU AU2021329034A patent/AU2021329034A1/en active Pending
- 2021-08-19 JP JP2023512002A patent/JP2023538581A/ja active Pending
- 2021-08-19 KR KR1020237009032A patent/KR20230051277A/ko unknown
- 2021-08-19 IL IL300509A patent/IL300509A/en unknown
- 2021-08-19 CN CN202180051162.6A patent/CN115916814A/zh active Pending
- 2021-08-19 WO PCT/EP2021/073094 patent/WO2022038250A1/en active Application Filing
- 2021-08-19 US US18/021,820 patent/US20230348850A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3190220A1 (en) | 2022-02-24 |
EP4200432A1 (en) | 2023-06-28 |
JP2023538581A (ja) | 2023-09-08 |
US20230348850A1 (en) | 2023-11-02 |
WO2022038250A1 (en) | 2022-02-24 |
KR20230051277A (ko) | 2023-04-17 |
AU2021329034A1 (en) | 2023-03-09 |
AR123289A1 (es) | 2022-11-16 |
BR112023002377A2 (pt) | 2023-03-21 |
CN115916814A (zh) | 2023-04-04 |
GB202012991D0 (en) | 2020-10-07 |
IL300509A (en) | 2023-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201991607A1 (ru) | Генетически модифицированные клетки-натуральные киллеры | |
MX2022012189A (es) | Composiciones que comprenden una variante del polipéptido cas12i2 y usos de las mismas. | |
MX2019003427A (es) | Composiciones para cultivo celular y metodos para la produccion de polipeptidos. | |
SG10201901417UA (en) | Production of proteins in glutamine-free cell culture media | |
MX2021014286A (es) | Proteinas multiespecificas. | |
MY189314A (en) | Cells for producing recombinant iduronate-2-sulfatase | |
EA201492185A1 (ru) | Способ получения рекомбинантной идуронат-2-сульфатазы | |
MX2020003798A (es) | Metodos para la purificacion de arilsulfatasa a. | |
WO2021257730A3 (en) | Cells modified by a cas12i polypeptide | |
MX2023014077A (es) | Composiciones de proteina anti-vegf y metodos para producir la misma. | |
EA202091349A1 (ru) | Способы культивирования клеток | |
MX2021015302A (es) | Metodos de purificacion de anticuerpos y composiciones de estos. | |
MX2021015698A (es) | Integración dirigida de configuraciones aleatorias de ácidos nucleicos. | |
AU2018276376A1 (en) | Cell culture methods | |
PL439808A1 (pl) | Sposoby i kompozycje hodowli komórkowych do produkcji przeciwciał | |
ZA202305072B (en) | Cd1a antibodies and uses thereof | |
MX2023002054A (es) | Procesos de cultivo celular. | |
CA2830600C (en) | Compositions and methods for enhancing the pluripotency of stem cells | |
MX2015010887A (es) | Formulaciones y metodos para aumentar la produccion de proteinas recombinantes. | |
WO2022174099A3 (en) | Compositions comprising a variant cas12i4 polypeptide and uses thereof | |
MX2023012201A (es) | Procesos de cultivo celular. | |
EA202192893A1 (ru) | Среда для культивирования эукариотических клеток | |
MX2019011343A (es) | Un procedimiento para la purificacion de fragmentos de anticuerpos recombinantes. | |
MX2023013277A (es) | Proceso para la produccion de proteinas recombinantes. | |
MX2023010648A (es) | Novedosas combinaciones de anticuerpos y usos de estas. |